Lovegra Oral Jelly (Rose Flavour)

Lovegra Oral Jelly 100mg is a sildenafil oral jelly formulation marketed under the Lovegra brand. Product information from commercial pharmaceutical listings identifies sildenafil citrate equivalent to 100mg sildenafil as the active ingredient, with a rose-flavoured 5g sachet and commonly listed 7-sachet pack. Commercial listings identify Ajanta Pharma as the manufacturer/marketer.

Lovegra is commonly marketed for women and female sexual arousal concerns. However, sildenafil's established U.S. prescribing indication is treatment of erectile dysfunction in men; sildenafil is not FDA-approved for female sexual dysfunction. Any use for female sexual dysfunction should therefore be considered separately from the established sildenafil indication and discussed with a qualified healthcare professional.

Product Information

Brand

Lovegra

Active Ingredient

Sildenafil Citrate

Strength

100mg sildenafil equivalent

Dosage Form

Oral Jelly

Flavour

Rose

Sachet Size

5g

Common Pack

7 × 5g Sachets

Drug Class

Phosphodiesterase Type-5 (PDE5) Inhibitor

Route

Oral

Manufacturer / Marketed By

Ajanta Pharma, according to commercial product listings

Product Type

Sildenafil oral jelly

Prescription / Regulatory Status

Varies by country and finished-product registration

Lovegra Oral Jelly vs Sildenafil Tablet

The key difference is the dosage form, not the active pharmaceutical ingredient.

Lovegra Oral Jelly 100mg

• Sildenafil citrate equivalent to 100mg sildenafil
• Oral jelly formulation
• Rose flavour
• Commonly supplied as 5g single-use sachets
• Frequently listed in a 7-sachet pack

Sildenafil 100mg Tablet

• Conventional solid oral tablet
• Contains sildenafil citrate equivalent to 100mg sildenafil
• Established FDA-labeled use for erectile dysfunction in men

The jelly and tablet should not be considered automatically interchangeable products because excipients, formulation, labeling, and approved indications can differ by manufacturer and market.

Lovegra 100mg Rose Flavour Product Details

Commercial product documentation identifies the following formulation details:

• 100mg sildenafil equivalent per sachet
• 5g oral jelly sachet
• Rose flavour
• 7 sachets commonly supplied per box
• Oral administration
• Sildenafil citrate as the active ingredient

Packaging may vary between markets, so the actual carton and sachet should be checked for the manufacturer, batch number, expiry date, active ingredient, strength, and local registration information.

UAE & Dubai Availability

Search behavior in the UAE specifically includes Lovegra Dubai, Lovegra in UAE, Lovegra Oral Jelly 100mg, oral jelly UAE, oral jelly Dubai, sildenafil oral jelly 100mg, and related product queries. These are useful commercial search terms for the regional page, but availability of a particular sildenafil oral-jelly product depends on UAE pharmaceutical and import requirements.

Customers should verify the legal status, prescription requirements, and registered-product status applicable to the UAE before purchasing or importing sildenafil products.

How it works

Sildenafil is a PDE5 inhibitor. It inhibits phosphodiesterase type-5 and enhances the nitric-oxide/cGMP pathway, promoting vasodilation and increased blood flow in responsive tissues. Its established clinical effect in men with erectile dysfunction depends on sexual stimulation.

The mechanism does not mean that sildenafil is universally effective for female sexual dysfunction. Evidence and regulatory indications for women differ from the established male erectile-dysfunction indication.

Lovegra is commercially marketed as a female sexual-wellness/sexual-arousal product containing sildenafil. Commercial product descriptions promote it for female sexual arousal concerns and describe sildenafil's vasodilatory effect in genital tissue.

The important regulatory distinction is that sildenafil's established FDA-approved sexual-health indication is erectile dysfunction in men. FDA labeling does not establish Lovegra or sildenafil as an FDA-approved treatment for female sexual dysfunction.

Sildenafil can cause headache, flushing, dyspepsia, nasal congestion, abnormal vision, dizziness, nausea, back pain, myalgia, and rash. Blood-pressure-lowering effects may also occur.

Sildenafil is contraindicated with organic nitrates or nitric oxide donors because the combination can cause a potentially dangerous fall in blood pressure. It is also contraindicated with guanylate cyclase stimulators such as riociguat. Caution is required with alpha-blockers and certain antihypertensive medicines because of additive blood-pressure effects.

People with cardiovascular conditions for whom sexual activity is inadvisable should not use sildenafil without appropriate medical evaluation. Sudden loss of vision or hearing requires prompt medical attention, and an erection lasting more than four hours is a medical emergency.